{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T13:08:48Z","timestamp":1749820128595},"reference-count":25,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T00:00:00Z","timestamp":1526515200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>\n                  <jats:bold>Introduction<\/jats:bold>. It seems that there is a relationship between small intestinal bacterial overgrowth (SIBO) and non-alcoholic fatty liver disease (NAFLD). The main objective of this study was to evaluate the prevalence of SIBO among NAFLD patients.<\/jats:p>\n               <jats:p>\n                  <jats:bold>Methods<\/jats:bold>. In this descriptive-analytical cross-sectional study, 98 eligible NAFLD patients were evaluated for SIBO using hydrogen breath test (HBT). They were divided into SIBO-positive and SIBO-negative groups. Demographic, clinical, and laboratory data were obtained.<\/jats:p>\n               <jats:p>\n                  <jats:bold>Results<\/jats:bold>. Based on the HBT, 38 patients (39%) had bacteria overgrowth. There were no significant differences between SIBO-positive and SIBO-negative regarding demographic data and BMI classification (P &gt; 0.05). Biochemical variables, the results of abdominal ultrasound, and liver elastography did not show any significant difference between SIBO-positive and SIBO-negative patients (P &gt; 0.05). Patients with SIBO were found to have higher rates of bloating, while abdominal pain was more prevalent in SIBO-negative patients (P &lt; 0.001).<\/jats:p>\n               <jats:p>\n                  <jats:bold>Conclusions<\/jats:bold>. SIBO is prevalent in NAFLD and associated with bloating in these patients. Further studies are necessary to elucidate if therapeutic manipulation of gut microbiota reduces the risk of NAFLD, fibrosis, and liver cirrhosis.<\/jats:p>","DOI":"10.1515\/rjim-2017-0042","type":"journal-article","created":{"date-parts":[[2017,11,4]],"date-time":"2017-11-04T22:16:04Z","timestamp":1509833764000},"page":"85-89","source":"Crossref","is-referenced-by-count":5,"title":["Liver disease symptoms in non-alcoholic fatty liver disease and small intestinal bacterial overgrowth"],"prefix":"10.1515","volume":"56","author":[{"given":"Rahmatollah","family":"Rafiei","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, School of Medicine , Islamic Azad University , Najafabad Branch, Isfahan , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahboobeh","family":"Bemanian","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine , Islamic Azad University , Najafabad Branch, Isfahan , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fereshteh","family":"Rafiei","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine , Islamic Azad University , Najafabad Branch, Isfahan , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmood","family":"Bahrami","sequence":"additional","affiliation":[{"name":"School of Medicine , St. George\u2019s University , England"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lotfollah","family":"Fooladi","sequence":"additional","affiliation":[{"name":"Dr. Fooladi Laboratory , Amadegah St, Isfahan , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giti","family":"Ebrahimi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine , Islamic Azad University , Najafabad Branch, Isfahan , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmadreza","family":"Hemmat","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine , Islamic Azad University , Najafabad Branch, Isfahan , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Torabi","sequence":"additional","affiliation":[{"name":"Isfahan University of Medical Sciences , Isfahan , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2018,5,17]]},"reference":[{"key":"2021040609533875537_j_rjim-2017-0042_ref_001_w2aab3b7b1b1b6b1ab1ab1Aa","unstructured":"1. CALDWELL SH., CRESPO DM. The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease. J Hepatol. 2004; 40(4):578-84."},{"key":"2021040609533875537_j_rjim-2017-0042_ref_002_w2aab3b7b1b1b6b1ab1ab2Aa","doi-asserted-by":"crossref","unstructured":"2. LONARDO A., BYRNE C., CALDWELL S., CORTEZ-PINTO H., TARGHER G. Global epidemiology of nonalcoholic fatty liver disease: Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016; 64: 1388-1389.10.1002\/hep.28584","DOI":"10.1002\/hep.28584"},{"key":"2021040609533875537_j_rjim-2017-0042_ref_003_w2aab3b7b1b1b6b1ab1ab3Aa","doi-asserted-by":"crossref","unstructured":"3. FAN JG., SAIBARA T., CHITTURI S., KIM BI., SUNG JJ., CHUTAPUTTI A. What are the risk factors and settings for nonalcoholic fatty liver disease in Asia\u2013Pacific? J Gastroenterol Hepatol. 2007; 22(6):794-800.","DOI":"10.1111\/j.1440-1746.2007.04952.x"},{"key":"2021040609533875537_j_rjim-2017-0042_ref_004_w2aab3b7b1b1b6b1ab1ab4Aa","doi-asserted-by":"crossref","unstructured":"4. OGDEN CL., CARROLL MD., CURTIN LR., LAMB MM., FLEGAL KM. Prevalence of high body mass index in US children and adolescents, 2007-2008. JAMA. 2010; 303(3):242-9.","DOI":"10.1001\/jama.2009.2012"},{"key":"2021040609533875537_j_rjim-2017-0042_ref_005_w2aab3b7b1b1b6b1ab1ab5Aa","doi-asserted-by":"crossref","unstructured":"5. GAGGINI M., MORELLI M., BUZZIGOLI E., DEFRONZO RA., BUGIANESI E., GASTALDELLI A. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients. 2013; 5(5):1544-60.","DOI":"10.3390\/nu5051544"},{"key":"2021040609533875537_j_rjim-2017-0042_ref_006_w2aab3b7b1b1b6b1ab1ab6Aa","doi-asserted-by":"crossref","unstructured":"6. AL-BUSAFI SA., BHAT M., WONG P., GHALI P., DESCHENES M. Antioxidant therapy in nonalcoholic steatohepatitis. Hepat Res Treat. 2012; 22: 947575.","DOI":"10.1155\/2012\/947575"},{"key":"2021040609533875537_j_rjim-2017-0042_ref_007_w2aab3b7b1b1b6b1ab1ab7Aa","doi-asserted-by":"crossref","unstructured":"7. VIGAN\u00d2 M., VERGANI A., TROMBINI P., POZZI M., PALEARI F., PIPERNO A. Insulin resistance influences iron metabolism and hepatic steatosis in type II diabetes. Gastroenterology. 2000; 118(5):986-7.10.1016\/S0016-5085(00)70193-4","DOI":"10.1016\/S0016-5085(00)70193-4"},{"key":"2021040609533875537_j_rjim-2017-0042_ref_008_w2aab3b7b1b1b6b1ab1ab8Aa","doi-asserted-by":"crossref","unstructured":"8. COHEN B., NOVICK D., RUBINSTEIN M. Modulation of insulin activities by leptin. Science. 1996; 274(5290):1185.","DOI":"10.1126\/science.274.5290.1185"},{"key":"2021040609533875537_j_rjim-2017-0042_ref_009_w2aab3b7b1b1b6b1ab1ab9Aa","doi-asserted-by":"crossref","unstructured":"9. PAPPO I., BERCOVIER H., BERRY E., GALLILLY R., FEIGIN E., FREUND HR. Antitumor necrosis factor antibodies reduce hepatic steatosis during total parenteral nutrition and bowel rest in the rat. J Parenter Enteral Nutr. 1995; 19(1):80-2.","DOI":"10.1177\/014860719501900180"},{"key":"2021040609533875537_j_rjim-2017-0042_ref_010_w2aab3b7b1b1b6b1ab1ac10Aa","doi-asserted-by":"crossref","unstructured":"10. KIRSCH R., CLARKSON V., VERDONK RC., MARAIS AD., SHEPHARD EG., RYFFEL B., et al. Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency. J Gastroenterol Hepatol. 2006; 21(1):174-82.","DOI":"10.1111\/j.1440-1746.2005.04220.x"},{"key":"2021040609533875537_j_rjim-2017-0042_ref_011_w2aab3b7b1b1b6b1ab1ac11Aa","doi-asserted-by":"crossref","unstructured":"11. BOND JR JH., LEVITT MD. Use of pulmonary hydrogen (H2) measurements to quantitate carbohydrate absorption: study of partially gastrectomized patients. J Clin Invest. 1972; 51(5):1219.10.1172\/JCI106916","DOI":"10.1172\/JCI106916"},{"key":"2021040609533875537_j_rjim-2017-0042_ref_012_w2aab3b7b1b1b6b1ab1ac12Aa","doi-asserted-by":"crossref","unstructured":"12. SABAT\u00c9 J-M., JOU\u00cbT P., HARNOIS F., MECHLER C., MSIKA S., GROSSIN M., et al. High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. Obes Surg. 2008; 18(4):371-7.10.1007\/s11695-007-9398-2","DOI":"10.1007\/s11695-007-9398-2"},{"key":"2021040609533875537_j_rjim-2017-0042_ref_013_w2aab3b7b1b1b6b1ab1ac13Aa","doi-asserted-by":"crossref","unstructured":"13. CORAZZA GR., STROCCHI A., GASBARRINI G. Fasting breath hydrogen in celiac disease. Gastroenterology. 1987; 93(1):53-8.","DOI":"10.1016\/0016-5085(87)90313-1"},{"key":"2021040609533875537_j_rjim-2017-0042_ref_014_w2aab3b7b1b1b6b1ab1ac14Aa","doi-asserted-by":"crossref","unstructured":"14. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation. 2002; 106:3143-3421.","DOI":"10.1161\/circ.106.25.3143"},{"key":"2021040609533875537_j_rjim-2017-0042_ref_015_w2aab3b7b1b1b6b1ab1ac15Aa","doi-asserted-by":"crossref","unstructured":"15. WIGG A., ROBERTS-THOMSON I., DYMOCK R., MCCARTHY P., GROSE R., CUMMINS A. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor \u03b1 in the pathogenesis of non-alcoholic steatohepatitis. Gut. 2001; 48(2):206-11.10.1136\/gut.48.2.206","DOI":"10.1136\/gut.48.2.206"},{"key":"2021040609533875537_j_rjim-2017-0042_ref_016_w2aab3b7b1b1b6b1ab1ac16Aa","doi-asserted-by":"crossref","unstructured":"16. SHANAB AA., SCULLY P., CROSBIE O., BUCKLEY M., O\u2019MAHONY L., SHANAHAN F., et al. Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8. Dig Dis Sci. 2011; 56(5):1524-34.","DOI":"10.1007\/s10620-010-1447-3"},{"key":"2021040609533875537_j_rjim-2017-0042_ref_017_w2aab3b7b1b1b6b1ab1ac17Aa","doi-asserted-by":"crossref","unstructured":"17. RUIZ AG., CASAFONT F., CRESPO J., CAY\u00d3N A., MAYORGA M., ESTEBANEZ A., et al. Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis. Obes Surg. 2007; 17(10):1374-80.","DOI":"10.1007\/s11695-007-9243-7"},{"key":"2021040609533875537_j_rjim-2017-0042_ref_018_w2aab3b7b1b1b6b1ab1ac18Aa","doi-asserted-by":"crossref","unstructured":"18. BELLOT P., FRANC\u00c9S R., SUCH J. Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications. Liver Int. 2013; 33(1):31-9.","DOI":"10.1111\/liv.12021"},{"key":"2021040609533875537_j_rjim-2017-0042_ref_019_w2aab3b7b1b1b6b1ab1ac19Aa","doi-asserted-by":"crossref","unstructured":"19. WIEST R., LAWSON M., GEUKING M. Pathological bacterial translocation in liver cirrhosis. J Hepatol. 2014; 60(1):197-209.","DOI":"10.1016\/j.jhep.2013.07.044"},{"key":"2021040609533875537_j_rjim-2017-0042_ref_020_w2aab3b7b1b1b6b1ab1ac20Aa","doi-asserted-by":"crossref","unstructured":"20. GUPTA A., DHIMAN RK., KUMARI S., RANA S., AGARWAL R., DUSEJA A., et al. Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy. J Hepatol. 2010; 53(5):849-55.10.1016\/j.jhep.2010.05.017","DOI":"10.1016\/j.jhep.2010.05.017"},{"key":"2021040609533875537_j_rjim-2017-0042_ref_021_w2aab3b7b1b1b6b1ab1ac21Aa","doi-asserted-by":"crossref","unstructured":"21. MIELE L., VALENZA V., LA TORRE G., MONTALTO M., CAMMAROTA G., RICCI R., et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology. 2009; 49(6):1877-87.","DOI":"10.1002\/hep.22848"},{"key":"2021040609533875537_j_rjim-2017-0042_ref_022_w2aab3b7b1b1b6b1ab1ac22Aa","doi-asserted-by":"crossref","unstructured":"22. PARNELL JA., RAMAN M., RIOUX KP., REIMER RA. The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance. Liver Int. 2012; 32(5):701-11.10.1111\/j.1478-3231.2011.02730.x","DOI":"10.1111\/j.1478-3231.2011.02730.x"},{"key":"2021040609533875537_j_rjim-2017-0042_ref_023_w2aab3b7b1b1b6b1ab1ac23Aa","doi-asserted-by":"crossref","unstructured":"23. XU R-Y., WAN Y-P., FANG Q-Y., LU W., CAI W. Supplementation with probiotics modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic fatty liver disease model. J Clin Biochem Nutr. 2011; 50(1):72-7.","DOI":"10.3164\/jcbn.11-38"},{"key":"2021040609533875537_j_rjim-2017-0042_ref_024_w2aab3b7b1b1b6b1ab1ac24Aa","doi-asserted-by":"crossref","unstructured":"24. PARLESAK A., KLEIN B., SCHECHER K., BODE JC., BODE C. Prevalence of small bowel bacterial overgrowth and its association with nutrition intake in nonhospitalized older adults. J Am Geriatr Soc. 2003; 51(6):768-73.10.1046\/j.1365-2389.2003.51259.x","DOI":"10.1046\/j.1365-2389.2003.51259.x"},{"key":"2021040609533875537_j_rjim-2017-0042_ref_025_w2aab3b7b1b1b6b1ab1ac25Aa","doi-asserted-by":"crossref","unstructured":"25. ALKHOURI N., CIKACH F., ENG K., MOSES J., PATEL N., YAN C., et al. Analysis of breath volatile organic compounds as a noninvasive tool to diagnose nonalcoholic fatty liver disease in children. Eur J Gastroenterol Hepatol. 2014; 26:82-7.","DOI":"10.1097\/MEG.0b013e3283650669"}],"container-title":["Romanian Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/content.sciendo.com\/view\/journals\/rjim\/56\/2\/article-p85.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciendo.com\/article\/10.1515\/rjim-2017-0042","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T10:13:29Z","timestamp":1617704009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciendo.com\/article\/10.1515\/rjim-2017-0042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,17]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,5,17]]},"published-print":{"date-parts":[[2018,6,1]]}},"alternative-id":["10.1515\/rjim-2017-0042"],"URL":"https:\/\/doi.org\/10.1515\/rjim-2017-0042","relation":{},"ISSN":["2501-062X"],"issn-type":[{"type":"electronic","value":"2501-062X"}],"subject":[],"published":{"date-parts":[[2018,5,17]]}}}